5 Biggest New Drug Approvals Potentially on the Way in 2019
AbbVie (NYSE: ABBV) and Novartis (NYSE: NVS) scored key drug approvals by the U.S. Food and Drug Administration (FDA) earlier this year. Each of the two companies landed products in market researcher EvaluatePharma's top-five list of the biggest new drugs approved so far in 2019.
But what about important FDA approvals that could be on the way in the remaining months of the year? EvaluatePharma also ranked the five biggest potential new drug approvals on the way in 2019. AbbVie and Novartis made this list, too. So did big biotech Celgene (NASDAQ: CELG) and three smaller drugmakers, Acceleron Pharma (NASDAQ: XLRN), Ardelyx (NASDAQ: ARDX) and Intra-Cellular Therapies (NASDAQ: ITCI). Here's which of these companies' pipeline candidates ranked on EvaluatePharma's list.
Image source: Getty Images.
Source Fool.com
